Profile
FEMY ISRG BDX ALC RMD WST
Company Name Femasys Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. West Pharmaceutical Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $24.68M $171.26B $68.86B $47.98B $34.38B $21.51B
Employees 0.03K 13.68K 70.00K 25.00K 9.98K 10.60K
CEO Ms. Kathy Lee-Sepsick M.B.A. Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM Mr. Eric M. Green
Ratings
FEMY ISRG BDX ALC RMD WST
Quant Rating Score 1 3 3 3 3 3
Quant Rating Strong Sell Neutral Neutral Neutral Neutral Neutral
Trading
FEMY ISRG BDX ALC RMD WST
Last Close $1.11 $481.95 $238.22 $97.27 $233.98 $296.5
High 52 $2.22 $494.01 $267.23 $100.76 $252.92 $413
Low 52 $0.75 $258.49 $221.47 $69.56 $134.65 $277.16
Price vs. 52 Week High -50 % -2.44 % -10.86 % -3.46 % -7.49 % -28.21 %
Price vs. 52 Week Low 48 % 86.45 % 7.56 % 39.84 % 73.77 % 6.98 %
Total Return
FEMY ISRG BDX ALC RMD WST
1 Month Return 3.74 % 2.15 % 2.39 % 2.76 % -4.45 % -0.25 %
3 Month Return 0 % 8.61 % 4.59 % 8.74 % 20.15 % -8.08 %
6 Month Return -34.32 % 24.09 % -3.23 % 14.71 % 23.96 % -24.75 %
9 Month Return 18.09 % 49.44 % -1.6 % 29.56 % 40.26 % -12.66 %
YTD Return 13.85 % 42.86 % -2.3 % 24.51 % 36.02 % -15.8 %
1 Year Return -44.5 % 63 % -9.22 % 28.24 % 59.62 % -21.47 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
FEMY ISRG BDX ALC RMD WST
Dividend Yield Percentage (TTM) - - 1.6 % 0.27 % 0.84 % 0.27 %
Dividend Paid and Capex Coverage Ration (TTM) -40.05 % 1.16 % 2.18 % 2.05 % 3.53 % 1.66 %
Dividend Per Share (TTM) - - 3.8 % 0.26 % 1.97 % 0.8 %
Payout Ratio (TTM) - - 77.14 % 12.09 % 27.65 % 11.07 %
Growth
FEMY ISRG BDX ALC RMD WST
Asset Growth 64.28 % 19.02 % -0.29 % 1.35 % 1.79 % 5.88 %
Gross Profit Growth -128.27 % 12.71 % -3.62 % 18.11 % 10.75 % -0.62 %
Revenue Growth -11.13 % 14.49 % 2.66 % 15.77 % 10.95 % 2.18 %
Revenue 3 Year -21.04 % 63.36 % 10.28 % 46.5 % 44.86 % 36.66 %
Revenue 5 Year -11.79 % 85.79 % 9.38 % 39.86 % 74.97 % 70.83 %
Revenue 10 Year -11.79 % 223.26 % 63.97 % 53.48 % 189.94 % 101.93 %
EBIT Growth -25.07 % 45.86 % -7.49 % 87.58 % 22.29 % -7.9 %
Net Income Growth -25.04 % 35.98 % -16.58 % 190.75 % 13.75 % 1.28 %
Net Income 3 Yeari Growth Per Share -57.51 % 69.43 % 65.46 % 281.94 % 112.66 % 70.48 %
Net Income 5 Yeari Growth Per Share 3.37 % 54.83 % 330.62 % 525.33 % 145.63 % 185.26 %
Net Income 10 Yeari Growth Per Share 3.37 % 175.41 % -21.76 % 225.89 % 184.54 % 394.98 %
Operating Income Growth -25.07 % 45.86 % -7.49 % 87.58 % 22.29 % -7.9 %
Operating Cash Flow Growth (CFG) -5.11 % 21.67 % 13.52 % 21.73 % 102.11 % 7.25 %
Operating 3 Year CFG -74.82 % 22.09 % -17.7 % 78.55 % 87.99 % 63.45 %
Operating 5 Year CFG 21.64 % 50.62 % -5.85 % 28.82 % 197.13 % 167.61 %
Operating 10 Year CFG 21.64 % 111.85 % 35.21 % 11.44 % 244.62 % 229.88 %
EPS Growth 4.12 % 37.63 % -16.19 % 201.43 % 13.4 % 1.4 %
EPS Diluted Growth 4.12 % 37.81 % -15.99 % 198.57 % 13.63 % 1.94 %
Book Value Per Share -7.62 % 22.1 % 1.5 % 4.44 % 17.57 % 7.45 %
Share Holder 3 Year Equity Growth Per Share 127.08 % 36.28 % 5.73 % 8.65 % 66.6 % 54.52 %
Share Holder 5 Year Equity Growth Per Share 130.92 % 93.27 % 10.89 % -9.73 % 128.49 % 105.22 %
Share Holder 10 Year Equity Growth Per Share 130.92 % 290.63 % 248.77 % -13.54 % 166.2 % 197.74 %
Dividend Per Share Growth - - 2.5 % 19.49 % 9.12 % 5.5 %
Dividend 3 Year Growth Per Share - - 5.8 % - 23.08 % 17.87 %
Dividend 5 Year Growth Per Share - - 8.45 % - 29.8 % 34.66 %
Dividend 10 Year Growth Per Share - - 96.74 % - 91.97 % 99.23 %
Debt Growth 1132.43 % -4.26 % -1.16 % 1.48 % -44.68 % -2.8 %
Free Cash Flow Growth -2.56 % -21.79 % 27.41 % 21.44 % 130 % -5.67 %
Updated On 31 Dec 2023 31 Dec 2023 30 Sep 2023 31 Dec 2023 30 Jun 2024 31 Dec 2023
Profitability
FEMY ISRG BDX ALC RMD WST
Gross Profit Margin TTM -5.92 % 66.86 % 42.06 % 55.29 % 57.92 % 35.73 %
Return on Assets TTM -82.32 % 12.57 % 2.54 % 3.71 % 14.86 % 15.04 %
Return on Equity TTM -119.97 % 15.36 % 5.51 % 5.34 % 22.41 % 19.08 %
Return on Capital Employed TTM -92.49 % 12.88 % 4.77 % 5.27 % 22.14 % 20.72 %
Net Income Per EBT TTM 100.02 % 93.85 % 84.46 % 106.81 % 80.72 % 85.87 %
EBT Per Ebit TTM 101.29 % 114.25 % 71.56 % 71.49 % 95.83 % 103.3 %
EBIT Per Revenue TTM -1734.1 % 25.79 % 11.79 % 14.76 % 29.03 % 20.57 %
Cash Flow To Debt Ratio TTM -279.43 % 1671.71 % 20.42 % 39.25 % 191.3 % 331.45 %
Receivables Turnover TTM 10.27 6.09 7.64 4.74 5.19 5.73
Payables Turnover TTM 1.06 12.91 2.31 5.04 8.05 8.73
Inventory Turnover TTM 0.76 1.81 3.53 1.88 2.33 4.41
Fixed Asset Turnover TTM 28.42 % 183.94 % 304.2 % 208.76 % 650.22 % 175.95 %
Asset Turnover TTM 4.69 % 45.48 % 35.67 % 32.92 % 66.15 % 82.44 %
Operating Cash Flow Per Share TTM -0.67 4.05 13.62 3.77 9.54 10.31
Free Cash Flow Per Share TTM -0.68 0.54 11.13 2.2 8.76 4.89
Cash Per Share TTM 60.88 % 1340.06 % 1843.47 % 277.32 % 170.43 % 611.23 %
Operating Cash Flow Sales Ratio TTM -1556.32 % 18.96 % 19.9 % 19.09 % 30.82 % 26.15 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.5 % 13.43 % 81.67 % 58.41 % 91.8 % 47.46 %
Cash Flow Coverage Ratios TTM -279.43 % 1671.71 % 20.42 % 39.25 % 191.3 % 331.45 %
Price To Free Cash Flows Ratio TTM -1.63 887.83 21.37 44.01 26.73 60.23
Price To Operating Cash Flows Ratio TTM -1.67 119.15 17.49 25.77 24.53 28.77
Price Cash Flow Ratio TTM -1.67 119.15 17.49 25.77 24.53 28.77
Income Statement (TTM)
FEMY ISRG BDX ALC RMD WST
Revenue $0B $7.12B $19.37B $10.09B $4.69B $2.95B
Gross Profit $-0B $4.73B $8.17B $5.61B $2.61B $1.13B
Gross Profit Ratio -20.16% 66.39% 42.17% 55.57% 55.68% 38.28%
EBITDA $-0.01B $2.19B $4.72B $2.56B $1.6B $0.88B
Net Income $-0.01B $1.8B $1.48B $0.97B $1.02B $0.59B
EPS Diluted -0.93 5.03 4.94 2.09 6.92 7.88
Balance Sheet (MRQ)
FEMY ISRG BDX ALC RMD WST
Long Term Debt $0B $-0.08B $14.74B $4.59B $0.7B $0.16B
Total Liabilities $0.01B $2.04B $26.98B $8.99B $2.01B $0.95B
Total Equity $0.02B $13.4B $25.8B $20.62B $4.86B $2.88B
Total Investments $0B $4.59B $0.01B $0.28B $0.17B $0.21B
Total Debt $0.01B $0.09B $15.88B $5.14B $0.87B $0.31B
Total Assets $0.03B $15.44B $52.78B $29.6B $6.87B $3.83B
Cash Flow Statement (TTM)
FEMY ISRG BDX ALC RMD WST
Net Income $-0.01B $1.82B $1.53B $1.04B $1.02B $0.59B
Inventory $-0B $-0.71B $-0.02B $-0.29B $0.17B $-0.01B
Dividends Paid $0B $0B $-1.11B $-0.12B $-0.28B $-0.06B
Operating Cash Flow $-0.01B $1.81B $2.99B $1.48B $1.4B $0.78B
Capital Expenditure $-0B $-1.06B $-0.87B $-0.91B $-0.11B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 2.78
ALC Alcon Inc. 97.27
ANGO AngioDynamics, Inc. 6.1
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 160.58
ATRC AtriCure, Inc. 27.63
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 1.01
AZTA Azenta, Inc. 48.27
BAX Baxter International Inc. 36.32
BDX Becton, Dickinson and Company 238.22
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 19
BLFS BioLife Solutions, Inc. 24.54
COO The Cooper Companies, Inc. 105.92
DXR Daxor Corporation 8.6075
EKSO Ekso Bionics Holdings, Inc. 1.04
GCTK GlucoTrack, Inc. 2.1585
GMVD G Medical Innovations Holdings Ltd 0.1835
ETFs With Exposure to FEMY
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 282.75
VXF Vanguard Extended Market Index Fund 0 181.77
DFAS Dimensional U.S. Small Cap ETF 0.00006446 64.38
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 137.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 137.9
VEMPX Vanguard Extended Market Index InstlPlus 0 340.28
Unlock